The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer

被引:4
|
作者
Aristei, C. [1 ,2 ]
Kaidar-Person, O. [3 ]
Boersma, L. [4 ]
Leonardi, M. C. [5 ]
Offersen, B. [6 ]
Franco, P. [7 ,8 ]
Arenas, M. [9 ]
Bourgier, C. [10 ]
Pfeffer, R. [11 ]
Kouloulias, V [12 ]
Bolukbasi, Y. [13 ]
Meattini, I [14 ,15 ]
Coles, C. [16 ]
Luis, A. Montero [17 ]
Masiello, V. [18 ]
Palumbo, I. [1 ,2 ]
Morganti, A. G. [19 ,20 ]
Perrucci, E. [21 ]
Tombolini, V. [22 ]
Krengli, M. [23 ,24 ]
Marazzio, F. [25 ]
Trigo, L.
Borghesi, S. [26 ]
Ciabattoni, A. [27 ]
Ratosa, I. [28 ,29 ]
Valentini, V. [30 ,31 ]
Poortmans, P. [32 ,33 ]
机构
[1] Univ Perugia, Radiat Oncol Sect, Dept Med & Surg, I-06156 Perugia, Italy
[2] Perugia Gen Hosp, I-06156 Perugia, Italy
[3] Sheba Med Ctr, Breast Radiat Unit, Radiat Oncol, Ramat Gan, Israel
[4] Maastricht Univ, GROW Sch Oncol & Dev Biol, Med Ctr, Radiat Oncol Maastro, Maastricht, Netherlands
[5] IRCCS, IEO European Inst Oncol, Div Radiat Oncol, Milan, Italy
[6] Aarhus Univ Hosp, Danish Ctr Particle Therapy, Dept Expt Clin Oncol, Dept Oncol, Aarhus, Denmark
[7] Univ Piemonte Orientale, Depatment Translat Med, Novara, Italy
[8] Maggiore Carita Univ Hosp, Dept Radiat Oncol, Novara, Italy
[9] Univ Rovira I Virgili, Hosp Universitari St Hoan Reus, IISPV, Radiat Oncol Dept, Tarragona, Spain
[10] Univ Montpellier, ICM Val Aurelle, Radiat Oncol, Montpellier, France
[11] Tel Aviv & Ben Gur Univ, Oncol Inst, Med Sch, Assuta Med Ctr, Beer Sheva, Israel
[12] Natl & Kapodistrian Univ Athens, Med Sch, Dept Radiol 2, Radiotherapy Unit, Zografos, Greece
[13] Koc Univ, Fac Med, Dept Radiat Oncol, Istanbul, Turkiye
[14] Univ Florence, Dept Expt & Clin Biomed Sci M Serio, Thales, Italy
[15] Azienda Ospedaliero Univ Careggi, Oncol Dept, Radiat Oncol Unit, Florence, Italy
[16] Univ Cambridge, Dept Oncol, Cambridge, England
[17] Hosp Univ HM Sanchinarro, HM Hosp, Dept Radiat Oncol, Madrid, Spain
[18] Fdn Policlin Gemelli IRCSS Roma, Dipartimento Diagnost Immagini, Unita Operativa Radioterapia Oncolog, Radioterapia Oncolog Ematol, Rome, Italy
[19] Alma Mater Studiorum Univ Bologna, DIMES, Bologna, Italy
[20] Alma Mater Studiorum Bologna Univ, IRCCS Azienda Ospedaliero Univ Bologna, Radiat Oncol, Bologna, Italy
[21] Perugia Gen Hosp, Radiat Oncol Sect, Perugia, Italy
[22] Univ Roma La Sapienza, Dept Radiol Oncol & Pathol Sci, Radiat Oncol, Rome, Italy
[23] Univ Padua, Padua, Italy
[24] Ist Oncol Veneto IRCCS, Padua, Italy
[25] Inst Portugues Oncol Porto Francisco Gentil EPE, Dept Image & Radioncol, Serv Brachytherapy, Porto, Portugal
[26] Azienda USL Toscana Sud Est, Radiat Oncol Unit Arezzo Valdarno, Arezzo, Italy
[27] San Filippo Neri Hosp, Clin & Rehabil Cardiol Unit, ASL Rome 1, Rome, Italy
[28] Inst Oncol Ljubljana, Div Radiat Oncol, Ljubljana, Slovenia
[29] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[30] Univ Cattolica Sacro Cuore, Dipartimento Diagnost Immagini, Radioterapia Oncol & Ematol, Milan, Iran
[31] Fdn Policlin Gemelli IRCSS Roma, Rome, Iran
[32] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium
[33] Fac Med & Hlth Sci, Iridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium
关键词
Breast cancer; Radiation therapy; Combined modality treatment; Immunotherapy; Re-irradiation in relapsed patients; 2ND CONSERVATIVE TREATMENT; TARGET VOLUME DELINEATION; PEMBROLIZUMAB PLUS CHEMOTHERAPY; ESTRO CONSENSUS GUIDELINE; NEOADJUVANT CHEMOTHERAPY; SURVIVAL OUTCOMES; INTERNAL MAMMARY; SENTINEL NODE; TUMOR EVENT; OPEN-LABEL;
D O I
10.1016/j.critrevonc.2023.104035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present white paper, referring to the 4th Assisi Think Tank Meeting on breast cancer, reviews state-of-the-art data, on-going studies and research proposals. <70% agreement in an online questionnaire identified the following clinical challenges: 1: Nodal RT in patients who have a) 1-2 positive sentinel nodes without ALND (axillary lymph node dissection); b) cN1 disease transformed into ypN0 by primary systemic therapy and c) 1-3 positive nodes after mastectomy and ALND. 2. The optimal combination of RT and immunotherapy (IT), patient selection, IT-RT timing, and RT optimal dose, fractionation and target volume. Most experts agreed that RT-IT combination does not enhance toxicity. 3: Re-irradiation for local relapse converged on the use of partial breast irradiation after second breast conserving surgery. Hyperthermia aroused support but is not widely available. Further studies are required to finetune best practice, especially given the increasing use of re-irradiation.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] The 2016 Assisi Think Tank Meeting on breast cancer: white paper
    Aristei, Cynthia
    Kaidar-Person, Orit
    Arenas, Meritxell
    Coles, Charlotte
    Offersen, Birgitte V.
    Bourgier, Celine
    Frezza, Giovanni
    Leonardi, Maria Cristina
    Valentini, Vincenzo
    Poortmans, Philip M. P.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 211 - 221
  • [2] The 2016 Assisi Think Tank Meeting on breast cancer: white paper
    Cynthia Aristei
    Orit Kaidar-Person
    Meritxell Arenas
    Charlotte Coles
    Birgitte V. Offersen
    Celine Bourgier
    Giovanni Frezza
    Maria Cristina Leonardi
    Vincenzo Valentini
    Philip M. P. Poortmans
    Breast Cancer Research and Treatment, 2016, 160 : 211 - 221
  • [3] The 2018 assisi think tank meeting on breast cancer: International expert panel white paper
    Arenas, Meritxell
    Selek, Ugur
    Kaidar-Person, Orit
    Perrucci, Elisabetta
    Montero Luis, Angel
    Boersma, Liesbeth
    Coles, Charlotte
    Offersen, Birgitte
    Meattini, Icro
    Bolukbasi, Yasemin
    Leonardi, Maria Cristina
    Pfeffer, Raphael
    Cutuli, Bruno
    Vidali, Cristiana
    Franco, Pierfrancesco
    Kouloulias, Vassilis
    Masiello, Valeria
    Rivera, Sofia
    Bourgier, Celine
    Ciabattoni, Antonella
    Lancellotta, Valentina
    Trigo, Lurdes
    Valentini, Vincenzo
    Poortmans, Philip
    Aristei, Cynthia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 151
  • [4] The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper
    Valentini, Vincenzo
    Marijnen, Corrie
    Beets, Geerard
    Bujko, Krzysztof
    De Bari, Berardino
    Cervantes, Andres
    Chiloiro, Giuditta
    Coco, Claudio
    Gambacorta, Maria Antonietta
    Glynne-Jones, Robert
    Haustermans, Karin
    Meldolesi, Elisa
    Peters, Femke
    Rodel, Claus
    Ruttenm, Harm
    van de Velde, Cornelis
    Aristei, Cynthia
    RADIOTHERAPY AND ONCOLOGY, 2020, 142 : 6 - 16
  • [5] The Assisi think tank focus review on postoperative radiation for lobular breast cancer
    Kaidar-Person, O.
    Ratosa, I
    Franco, P.
    Masiello, V.
    Marazzi, F.
    Pedretti, S.
    Ciabattoni, A.
    Leonardi, M. C.
    Tramm, T.
    Coles, Ce
    Meattini, I
    Arenas, M.
    Offersen, B. V.
    Boersma, L. J.
    Valentini, V.
    Dodwell, D.
    Poortmans, P.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2024, 201
  • [6] The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy
    Arenas, Meritxell
    Boluekbasi, Yasemin
    Boersma, Liesbeth J.
    Offersen, Birgitte
    Kouloulias, Vassilis
    Palumbo, Isabella
    Trigo, Lurdes
    Lozza, Laura
    Marazzi, Fabio
    Trovo, Marco
    Rivera, Sofia
    Kaidar-Person, Orit
    Coles, Charlotte
    Meattini, Icro
    Valentini, Vincenzo
    Aristei, Cynthia
    Poortmans, Philip
    BREAST, 2025, 80
  • [7] Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting
    Aristei, Cynthia
    Bolukbasi, Yasemin
    Kaidar-Person, Orit
    Pfeffer, Raphael
    Arenas, Meritxell
    Boersma, Liesbeth J.
    Ciabattoni, Antonella
    Coles, Charlotte E.
    Franco, Pierfrancesco
    Krengli, Marco
    Leonardi, Maria Cristina
    Marazzi, Fabio
    Masiello, Valeria
    Meattini, Icro
    Montero, Angel
    Offersen, Birgitte
    Trigo, Maria Lurdes
    Bourgier, Celine
    Genovesi, Domenico
    Kouloulias, Vassilis
    Morganti, Alessio G.
    Meduri, Bruno
    Pasinetti, Nadia
    Pedretti, Sara
    Perrucci, Elisabetta
    Rivera, Sofia
    Tombolini, Vincenzo
    Vidali, Cristiana
    Valentini, Vincenzo
    Poortmans, Philip
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 177
  • [8] The Assisi Think Tank Meeting Breast Large Database for Standardized Data Collection in Breast Cancer-ATTM.BLADE
    Marazzi, Fabio
    Masiello, Valeria
    Masciocchi, Carlotta
    Merluzzi, Mara
    Saldi, Simonetta
    Belli, Paolo
    Boldrini, Luca
    Capocchiano, Nikola Dino
    Di Leone, Alba
    Magno, Stefano
    Meldolesi, Elisa
    Moschella, Francesca
    Mule, Antonino
    Smaniotto, Daniela
    Terribile, Daniela Andreina
    Tagliaferri, Luca
    Franceschini, Gianluca
    Gambacorta, Maria Antonietta
    Masetti, Riccardo
    Valentini, Vincenzo
    Poortmans, Philip M. P.
    Aristei, Cynthia
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (02): : 1 - 11
  • [9] The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report
    Aristei, Cynthia
    Kaidar-Person, Orit
    Tagliaferri, Luca
    Arenas, Meritxell
    Coles, Charlotte E.
    Offersen, Birgitte V.
    Frezza, Giovanni
    Leonardi, Maria Cristina
    Valentini, Vincenzo
    Bourgier, Celine
    Poortmans, Philip M. P.
    EJSO, 2018, 44 (04): : 436 - 443
  • [10] The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice
    Montero-Luis, A.
    Aristei, C.
    Meattini, I.
    Arenas, M.
    Boersma, L.
    Bourgier, C.
    Coles, C.
    Cutuli, B.
    Falcinelli, L.
    Kaidar-Person, O.
    Leonardi, M. C.
    Offersen, B.
    Marazzi, F.
    Rivera, S.
    Tagliaferri, L.
    Tombolini, V.
    Vidali, C.
    Valentini, V.
    Poortmans, P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 138 : 207 - 213